Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

65.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.5K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

110.8K
Overview
110.8K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

7.8K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.8K
Antibody Actions01:26

Antibody Actions

2.7K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.7K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

11.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

3.4K
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes-related barriers to cancer screening in women with type 2 diabetes: A qualitative interview study.

British journal of health psychology·2026
Same author

Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice.

Diabetes care·2026
Same author

Managing Obesity in Individuals with Cardiovascular Disease: Are We Missing the Obvious?

European cardiology·2026
Same author

Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial.

The lancet. Diabetes & endocrinology·2026
Same author

Updated glucose management indicator (GMI) better aligns with HbA<sub>1c</sub> than current GMI: implications for clinical practice and reporting.

Diabetologia·2026
Same author

Glucagon-like peptide-1 receptor agonists for prevention of heart failure events in type 2 diabetes and/or obesity.

ESC heart failure·2026

Related Experiment Video

Updated: Jan 29, 2026

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
05:21

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay

Published on: September 13, 2024

898

New insights into antibody-mediated hyperthyroidism.

Ramzi A Ajjan1, Anthony P Weetman2

  • 1a Academic Unit of Molecular and Vascular Medicine, The LIGHT Laboratories, University of Leeds, Leeds LS2 9JT UK.

Expert Review of Endocrinology & Metabolism
|February 13, 2019
PubMed
Summary
This summary is machine-generated.

Graves' disease, an autoimmune disorder, is caused by thyroid-stimulating antibodies activating the thyroid-stimulating hormone receptor. Further research into these antibodies may reveal new treatment strategies for hyperthyroidism and its complications.

Keywords:
Graves’ diseaseGraves’ ophthalmopathyTSAbautoimmune thyroid diseasethyroid autoantigens

More Related Videos

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.7K

Related Experiment Videos

Last Updated: Jan 29, 2026

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
05:21

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay

Published on: September 13, 2024

898
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.7K

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Graves' disease is the most common cause of hyperthyroidism and a prime example of organ-specific autoimmunity.
  • The precise triggers for Graves' disease are unknown but likely involve genetic predisposition and environmental factors.
  • Thyroid-stimulating antibodies (TSAbs) activating the thyroid-stimulating hormone receptor (TSHR) are the hallmark of the condition, leading to hyperthyroidism.

Purpose of the Study:

  • To investigate the role of thyroid-stimulating antibodies in the pathogenesis of Graves' disease.
  • To explore the interaction between TSAbs and the TSHR.
  • To identify potential new therapeutic targets for hyperthyroidism and extrathyroidal manifestations.

Main Methods:

  • Generation of TSAbs in animal models.
  • Isolation of monoclonal TSAbs from Graves' disease patients.
  • Detailed study of TSAbs-TSHR interactions.

Main Results:

  • Successful generation of TSAbs in animal models.
  • Isolation of specific monoclonal TSAbs.
  • Established a foundation for studying TSAbs-TSHR interactions in detail.

Conclusions:

  • TSAbs are central to Graves' disease pathogenesis and may contribute to extrathyroidal complications.
  • Understanding TSAbs-TSHR interactions is crucial for elucidating disease mechanisms.
  • Further research holds promise for developing novel treatment strategies, especially for refractory cases and extrathyroidal involvement.